We are live on
!
Find out more
SO
STRS Ohio Portfolio holdings
AUM
$25.2B
1-Year Est. Return
30.31%
This Fund
S&P 500
This Quarter
Est. Return
+23.23%
1 Year Est. Return
+30.31%
3 Year Est. Return
+102.28%
5 Year Est. Return
+135.19%
10 Year Est. Return
+493.48%
AUM
$22.9B
AUM Growth
+$3.89B
(+20%)
Cap. Flow
-$22.2M
Cap. Flow
% of AUM
-0.1%
Top 10 Holdings %
Top 10 Hldgs %
23.15%
Holding
2,333
New
311
Increased
958
Reduced
613
Closed
176
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Golub Capital BDC
GBDC
|
+$74.9M |
| 2 |
Keysight
KEYS
|
+$52.1M |
| 3 |
Merck
MRK
|
+$40.9M |
| 4 |
AbbVie
ABBV
|
+$38.6M |
| 5 |
BioMarin Pharmaceuticals
BMRN
|
+$37.7M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AGN
Allergan plc
AGN
|
+$104M |
| 2 |
Match Group
MTCH
|
+$48.9M |
| 3 |
TransDigm Group
TDG
|
+$43.4M |
| 4 |
Stryker
SYK
|
+$43.1M |
| 5 |
Johnson & Johnson
JNJ
|
+$42.5M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 23.57% |
| 2 | Financials | 14.31% |
| 3 | Healthcare | 13.92% |
| 4 | Consumer Discretionary | 9.62% |
| 5 | Communication Services | 8.89% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SPTN
1076
DELISTED
SpartanNash
SPTN
| $711K | ﹤0.01% |
33,500
-7,600
| -18% | -$136K |
|
|
WIRE
1077
DELISTED
Encore Wire Corp
WIRE
| $707K | ﹤0.01% |
14,500
+1,200
| +9% | +$55.1K |
|
|
RAD
1078
DELISTED
Rite Aid Corporation
RAD
| $707K | ﹤0.01% |
+41,500
| New | +$559K |
|
|
CCXI
1079
DELISTED
ChemoCentryx, Inc.
CCXI
| $707K | ﹤0.01% |
12,300
+12,000
| +4,000% | +$653K |
|
1080
ePlus
PLUS
$2.33B
| $706K | ﹤0.01% |
20,000
| – | – |
|
1081
JELD-WEN Holding
JELD
$94.8M
| $704K | ﹤0.01% |
43,700
+3,600
| +9% | +$47.5K |
|
1082
Delek US
DK
$3.87B
| $703K | ﹤0.01% |
40,400
-1,200
| -3% | -$22.9K |
|
|
MODV
1083
DELISTED
ModivCare
MODV
| $702K | ﹤0.01% |
8,900
-500
| -5% | -$33.8K |
|
1084
Safety Insurance
SAFT
$1.52B
| $701K | ﹤0.01% |
9,200
+800
| +10% | +$62.6K |
|
1085
Novavax
NVAX
$1.23B
| $700K | ﹤0.01% |
+8,400
| New | +$321K |
|
1086
DNOW Inc
DNOW
$2.63B
| $696K | ﹤0.01% |
80,700
+5,200
| +7% | +$35.7K |
|
1087
Dynatrace
DT
$12.1B
| $694K | ﹤0.01% |
+17,114
| New | +$563K |
|
1088
Axcelis
ACLS
$4.12B
| $693K | ﹤0.01% |
+24,900
| New | +$607K |
|
1089
Primoris Services
PRIM
$4.69B
| $692K | ﹤0.01% |
39,000
+3,900
| +11% | +$61.5K |
|
1090
MillerKnoll
MLKN
$1.5B
| $687K | ﹤0.01% |
29,100
+2,400
| +9% | +$54.2K |
|
|
UCTT
1091
Ultra Clean Holdings
UCTT
$4.16B
| $687K | ﹤0.01% |
30,400
-2,000
| -6% | -$38K |
|
1092
Strategy Inc
MSTR
$33.5B
| $686K | ﹤0.01% |
58,000
+5,000
| +9% | +$60.8K |
|
|
RESI
1093
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $684K | ﹤0.01% |
78,662
+687
| +0.9% | +$6.29K |
|
1094
Enanta Pharmaceuticals
ENTA
$372M
| $682K | ﹤0.01% |
13,600
+1,100
| +9% | +$56.9K |
|
1095
Scholastic
SCHL
$796M
| $682K | ﹤0.01% |
22,800
+1,600
| +8% | +$46.1K |
|
1096
Acadia Pharmaceuticals
ACAD
$4.25B
| $677K | ﹤0.01% |
13,968
-25,332
| -64% | -$1.22M |
|
1097
CEVA Inc
CEVA
$1.01B
| $677K | ﹤0.01% |
18,100
-2,900
| -14% | -$93K |
|
1098
Clean Harbors
CLH
$16.1B
| $675K | ﹤0.01% |
11,256
-280
| -2% | -$15.6K |
|
1099
Arvinas
ARVN
$518M
| $674K | ﹤0.01% |
20,100
+5,400
| +37% | +$229K |
|
1100
Ultragenyx Pharmaceutical
RARE
$2.65B
| $672K | ﹤0.01% |
8,600
+4,200
| +95% | +$278K |
|
Similar funds
KK
VAI
UIM
STRS Ohio's Q2 2020 Portfolio in Review
As of Q2 2020, STRS Ohio held 2,333 positions worth $22.9B, up 20% from $19B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
STRS Ohio's Q2 2020 filing shows 311 new, 958 increased, 613 reduced and 176 closed positions. Its largest new stake was RTX Corp: 598,060 shares worth $36.9M. The largest sale was Allergan plc, an estimated $104M.
By sector, the portfolio is most concentrated in Technology at 24% of assets, up from 22% a quarter earlier, followed by Financials and Healthcare.
- STRS Ohio's largest Q2 2020 buy was RTX Corp: 598,060 shares worth $36.9M.
- STRS Ohio added most to Golub Capital BDC in Q2 2020, an estimated $74.9M increase.
- STRS Ohio's biggest Q2 2020 reduction was TransDigm Group, cutting an estimated $43.4M.
- STRS Ohio fully exited Allergan plc in Q2 2020, selling an estimated $104M.
- STRS Ohio's ten largest holdings make up 23% of its $22.9B portfolio in Q2 2020.
- STRS Ohio opened 311 new positions and closed 176 in Q2 2020.
- STRS Ohio's portfolio value rose 20% quarter-over-quarter to $22.9B.
Based on STRS Ohio's 13F filing for Q2 2020, filed 23 Jul 2020.